Since it is known that PGR can synergize with or antagonize ESR to influence downstream biological processes 11, it is important to develop the new type of PGR-specific small molecules for a simple and more effective treatment of HR+ breast cancers without the need of combination treatments. The gene discussed is PGR; the disease is breast carcinoma.